HSIC 📈 Henry Schein - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8064071025
HSIC: Dental Products, Medical Products, Software, Technology Services
Hospitality and care are at the core of Henry Schein Inc, a global provider of healthcare products and services. The company caters to a diverse range of clients, including dental practitioners, laboratories, physician practices, ambulatory surgery centers, government institutions, and various alternate care clinics worldwide. By operating through two distinct segments, Health Care Distribution and Technology and Value-Added Services, Henry Schein is able to provide a comprehensive suite of products and services that address the complex needs of the healthcare industry.
The Health Care Distribution segment is a critical component of Henry Schein's business, offering an extensive array of dental and medical products. This includes infection-control products, handpieces, preventatives, and restorative materials, as well as dental implants, equipment, and high-tech digital restoration equipment. The company also provides medical products, such as pharmaceuticals, vaccines, surgical products, and diagnostic tests, which are essential for medical practitioners. Furthermore, the segment offers equipment repair services, ensuring that healthcare providers can maintain their equipment and minimize downtime. By providing these products and services, Henry Schein plays a vital role in supporting the delivery of high-quality patient care.
Through its Technology and Value-Added Services segment, Henry Schein offers a range of innovative solutions designed to enhance the efficiency and productivity of healthcare practices. This includes practice management software systems, which enable dental and medical practitioners to streamline their operations, manage patient records, and optimize revenue cycle management. The company also provides value-added practice solutions, such as practice consultancy, education, and financial services, which help healthcare providers to improve their business operations and stay up-to-date with the latest industry developments. Additionally, Henry Schein offers e-services, practice technology, and network and hardware services, as well as consulting and continuing education services, all of which are designed to support the long-term success of healthcare practices.
With a rich history dating back to 1932, Henry Schein has established itself as a trusted and reliable partner to the healthcare industry. Headquartered in Melville, New York, the company has evolved over the years to become a leading global provider of healthcare products and services. Today, Henry Schein is listed on the NASDAQ stock exchange under the ticker symbol HSIC, and its common stock is classified under the GICS Sub Industry of Health Care Distributors. As a company, Henry Schein is committed to supporting the healthcare industry and contributing to the well-being of patients around the world.
Additional Sources for HSIC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HSIC Stock Overview
Market Cap in USD | 8,780m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC Sub-Industry | Health Care Distributors |
IPO / Inception | 1995-11-03 |
HSIC Stock Ratings
Growth 5y | 4.28% |
Fundamental | 11.6% |
Dividend | - |
Rel. Strength Industry | -209 |
Analysts | 3.29/5 |
Fair Price Momentum | 65.19 USD |
Fair Price DCF | 83.21 USD |
HSIC Dividends
No Dividends PaidHSIC Growth Ratios
Growth Correlation 3m | 4.1% |
Growth Correlation 12m | -34.4% |
Growth Correlation 5y | 27.4% |
CAGR 5y | 0.57% |
CAGR/Mean DD 5y | 0.04 |
Sharpe Ratio 12m | -0.12 |
Alpha | -24.17 |
Beta | 0.88 |
Volatility | 23.62% |
Current Volume | 900k |
Average Volume 20d | 1135k |
As of January 15, 2025, the stock is trading at USD 71.27 with a total of 900,010 shares traded.
Over the past week, the price has changed by -1.48%, over one month by -7.70%, over three months by -0.44% and over the past year by -3.14%.
Neither. Based on ValueRay Fundamental Analyses, Henry Schein is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.63 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HSIC as of January 2025 is 65.19. This means that HSIC is currently overvalued and has a potential downside of -8.53%.
Henry Schein has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold HSIC.
- Strong Buy: 2
- Buy: 3
- Hold: 7
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, HSIC Henry Schein will be worth about 71.2 in January 2026. The stock is currently trading at 71.27. This means that the stock has a potential downside of -0.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 74.8 | 5% |
Analysts Target Price | 81.6 | 14.6% |
ValueRay Target Price | 71.2 | -0.1% |